Author:
Torrealday Saioa,Patrizio Pasquale
Publisher
Springer International Publishing
Reference114 articles.
1. Balen AH, Morley LC, Misso M, Franks S, Legro RS, Wijeyaratne CN, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016;22(6):687–708.
2. The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril. 2008;89:505–22.
3. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus criteria and long-term health risks related to polycystic ovary syndrome society. Fertil Steril. 2004;81:19–25.
4. Balen AH, Conway GS, Kaltsas G, Techatraisak K, Manning PJ, West C, et al. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod. 1995;8:2107–11.
5. Stubbs SA, Hardy K, Da Silva-Buttkus P, Stark LJ, Webber AM, Flanagan AP, et al. Anti-mullerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries. J Clin Endocrinol Metab. 2005;90:5536–43.